Pay-For-Delay Ban, Other Drug Price Bills Advance In House
The House Judiciary Committee advanced four bills Tuesday aimed at reducing prescription drug costs, including a measure that would ban most so-called pay-for-delay settlements of patent lawsuits between branded and generic pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article